DCM Shriram Limited — Investor Meet, 27-01-2025: Analysts/Institutional Investor Meet/Con. Call Updates

**Financial Performance:** DCM Shriram reported net revenues of ₹3,367 crore for the quarter, reflecting an 11% year-on-year increase. The company achieved a PBDIT of ₹537 crore, up 12% from the previous year. Key drivers included strong performance in chemicals, agriculture, and Bioseed segments. Chemicals revenue surged by 35% due to increased caustic soda volumes of 21% and a 90% rise in PBDIT, attributed to lower input costs. The vinyl segment reported revenue growth of 26% due to higher volumes, while sugar and ethanol segments experienced flat revenue at ₹889 crore, impacted by operational challenges.

**Future Outlook and Growth Drivers:** Management expressed optimism for continued growth, emphasizing upcoming initiatives such as increased capacity in chemicals and sustainable practices. The company aims to optimize costs and streamline operations, including projects in renewable energy.

**Order Book and Operational Updates:** The construction of new Aluminum Chloride and Calcium Chloride plants is progressing according to schedule, with production capabilities expected to enhance chemical utilization rates.

**Analyst Q&A Insights:** Analysts sought clarification on profitability and market position. DCM Shriram's management cited improving ECU numbers for caustic soda as a positive indicator. Concerns were raised about potential market oversupply impacting chlorine pricing, with assurance that cost optimization efforts are underway. Capex plans included a focus on advanced materials, emphasizing the importance of sustaining growth.

**Market or Regulatory Updates:** Discussions highlighted pending anti-dumping duties impacting PVC imports, with management hopeful for timely resolutions post-budget session.

**Strategic Focus Areas:** DCM Shriram appears focused on enhancing its sustainability framework while expanding its product portfolio. The tone of management indicated confidence in navigating operational challenges.

**Investor Insight:** Financial health and strategic growth potential suggest a favorable outlook. Current developments and strong operational results align with a 'buy' position, taking into consideration potential risks associated with market volatility.